Dr Jessamy Tiffen leads the Epigenetics of Melanoma Program at the Centenary Institute. She is an expert in the study of epigenetic regulation in cancer. She has an excellent publication record and citations in high impact factor journals including Nature Genetics, Lancet Oncology, JNCI and Cancer Research. She is the recipient of grants from the Cancer Council of NSW and Tour de Cure. She was recently awarded a Centenary Institute Future Fellowship and holds a dual affiliation as an Honorary Senior Research Fellow within the University of Sydney (USYD).
In 2011 she completed her PhD from USYD in Cancer genetics. From there she underwent postdoctoral training at the Welcome Trust Sanger Institute in Cambridge, UK under the mentorship of Dr David Adams. Upon returning to Australia she pursued her interest in melanoma at the Kolling Institute of Medical Research with Professor Peter Hersey who relocated with his team to Centenary Institute in 2015. She was a mentee in the Franklin Women Mentoring program in 2018. She is also a member of the American Association of Cancer Research and the Society for Melanoma Research.
